Literature DB >> 2105714

The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.

T L Lindahl1, P I Ohlsson, B Wiman.   

Abstract

The structural events taking place during the reaction between PAI-1 (plasminogen-activator inhibitor 1) and the plasminogen activators sc-tPA (single-chain tissue plasminogen activator) and tc-tPA (two-chain tissue plasminogen activator) were studied. Complexes were formed by mixing sc-tPA or tc-tPA with PAI-1 in slight excess (on an activity basis). The complexes were purified from excess PAI-1 by affinity chromatography on fibrin-Sepharose. Examination of the purified complexes by SDS/polyacrylamide-gel electrophoresis (SDS/PAGE) and N-terminal amino acid sequence analysis demonstrated that a stoichiometric 1:1 complex is formed between PAI-1 and both forms of tPA. Data obtained from both complexes revealed the amino acid sequences of the parent molecules and, in addition, a new sequence: Met-Ala-Pro-Glu-Glu-. This sequence is found in the C-terminal portion of the intact PAI-1 molecule and thus locates the reactive centre of PAI-1 to Arg346-Met347. The proteolytic activity of sc-tPA is demonstrated by its capacity to cleave the 'bait' peptide bond in PAI-1. The complexes were inactive and dissociated slowly at physiological pH and ionic strength, but rapidly in aq. NH3 (0.1 mol/l). Amidolytic tPA activity was generated on dissociation of the complexes, corresponding to 0.4 mol of tPA/mol of complex. SDS/PAGE of the dissociated complexes indicated a small decrease in the molecular mass of PAI-1, in agreement with proteolytic cleavage of the 'bait' peptide bond during complex-formation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105714      PMCID: PMC1136620          DOI: 10.1042/bj2650109

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

2.  Comparison of plasminogen activator inhibitor activity and antigen in plasma samples.

Authors:  G Urdén; A Hamsten; B Wiman
Journal:  Clin Chim Acta       Date:  1987-11-16       Impact factor: 3.786

3.  The molecular stoichiometry of trypsin inhibition by human alpha-1-proteinase inhibitor.

Authors:  D A Johnson; R N Pannell; J Travis
Journal:  Biochem Biophys Res Commun       Date:  1974-04-08       Impact factor: 3.575

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Human plasma proteinase inhibitors.

Authors:  J Travis; G S Salvesen
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

6.  On the structure of the stable complex between plasmin and alpha-2-antiplasmin.

Authors:  T Nilsson; B Wiman
Journal:  FEBS Lett       Date:  1982-06-01       Impact factor: 4.124

7.  Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor.

Authors:  B Wiman; J Chmielewska; M Rånby
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

8.  Evidence for the formation of an ester between thrombin and heparin cofactor.

Authors:  W G Owen
Journal:  Biochim Biophys Acta       Date:  1975-10-20

9.  Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.

Authors:  T Nilsson; I Sjöholm; B Wiman
Journal:  Biochem J       Date:  1983-09-01       Impact factor: 3.857

10.  Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.

Authors:  T Lindahl; B Wiman
Journal:  Biochim Biophys Acta       Date:  1989-02-23
View more
  9 in total

1.  Tissue-type plasminogen activator gene targets thrombolysis in atriums.

Authors:  Yongsheng Gong; Fajiu Wang; Xia Li; Zhixin Gao; Kailun Zhang; Chen Fan; Xingen Liu
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

2.  Small Molecule PAI-1 Functional Inhibitor Attenuates Vascular Smooth Muscle Cell Migration and Survival: Implications for the Therapy of Vascular Disease.

Authors:  Tessa M Simone; Paul J Higgins
Journal:  New Horiz Transl Med       Date:  2014-09-01

Review 3.  Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women.

Authors:  Tatjana Elène Vogelvang; Marius Jan van der Mooren; Velja Mijatovic; Peter Kenemans
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Functional effects of single amino acid substitutions in the region of Phe113 to Asp138 in the plasminogen activator inhibitor 1 molecule.

Authors:  G C Sui; B Wiman
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

5.  Tryptophan properties in fluorescence and functional stability of plasminogen activator inhibitor 1.

Authors:  Stefan Verheyden; Alain Sillen; Ann Gils; Paul J Declerck; Yves Engelborghs
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

6.  A Case of Unexplained Cerebral Sinus Thrombosis in a 22-Year-Old Obese Caucasian Woman.

Authors:  Jansen N Seheult; Irina Chibisov
Journal:  Lab Med       Date:  2016-06-10

7.  A small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavage.

Authors:  Tessa M Simone; Stephen P Higgins; Jaclyn Archambeault; Craig E Higgins; Roman G Ginnan; Harold Singer; Paul J Higgins
Journal:  Cell Signal       Date:  2015-01-22       Impact factor: 4.315

8.  Significant decrease of von Willebrand factor and plasminogen activator inhibitor-1 by providing supplementation with selenium and coenzyme Q10 to an elderly population with a low selenium status.

Authors:  Urban Alehagen; J Alexander; J Aaseth; A Larsson; T L Lindahl
Journal:  Eur J Nutr       Date:  2020-02-20       Impact factor: 5.614

9.  Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome.

Authors:  Malgorzata Wygrecka; Rory E Morty; Philipp Markart; Sandip M Kanse; Peter A Andreasen; Troels Wind; Andreas Guenther; Klaus T Preissner
Journal:  J Biol Chem       Date:  2007-05-31       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.